Indian Firm Panacea Says Aiming to Make Covid-19 Vaccine
FILE PHOTO: Small bottles classified with a “Vaccine COVID-19” decal and a clinical syringe are observed on this representation taken taken April 10, 2020. REUTERS/Dado Ruvic/Representation
The collaboration targets to make greater than 500 million doses of the vaccine candidate, with over 40 million doses anticipated to be to be had early subsequent yr, Panacea stated in a observation to inventory exchanges.
- Reuters Bengaluru
- Closing Up to date: June 10, 2020, 11:15 AM IST
Indian biotech company Panacea Biotec Ltd stated on Wednesday it could spouse with US-based Refana Inc to make a possible vaccine for Covid-19.
The collaboration targets to make greater than 500 million doses of the vaccine candidate, with over 40 million doses anticipated to be to be had early subsequent yr, Panacea stated in a observation to inventory exchanges.
Panacea’s stocks jumped 20 consistent with cent in morning buying and selling on India’s Nationwide Inventory Trade after the scoop.
https://pubstack.nw18.com/pubsync/fallback/api/movies/really helpful?supply=n18english&channels=5d95e6c378c2f2492e2148a2&classes=5d95e6d7340a9e4981b2e10a&question=Indian,Company,Panacea,Says,Aiming,to,Make,Covid-19,Vaccine,coronavirus,indian,&publish_min=2020-06-09T04:36:46.000Z&publish_max=2020-06-11T04:36:46.000Z&sort_by=date-relevance&order_by=zero&restrict=2
